Allied Health and Human Performance, University of South Australia, Adelaide, Australia.
Adelaide Gastrointestinal Specialists, North Adelaide, South Australia, Australia.
J Gastrointest Surg. 2022 Nov;26(11):2249-2254. doi: 10.1007/s11605-022-05438-2. Epub 2022 Aug 25.
A very low-calorie diet (VLCD) or low-calorie diet (LCD) is often used prior to laparoscopic surgery to optimize access to the hiatus. Much debate exists in the literature regarding the required duration for a VLCD or LCD, and how to evaluate the presence of a fatty liver. The aim of our study was to determine the optimal amount of time on an LCD to achieve maximal liver volume reduction, and to assess the accuracy of the InBody 230® vs. bedside ultrasonography vs. magnetic resonance imaging (MRI) in the measurement of liver volume.
Seventeen consecutive patients undergoing laparoscopic anti-reflux surgery were recruited into the study. Each patient underwent body composition analysis with the InBody® 230, liver ultrasound, and liver MRI. Patients then began an LCD with a weekly ultrasound assessment until the day before surgery when they underwent repeat body composition analysis, liver ultrasound, and MRI.
The mean age was 54 years (range 21, 74). Maximal liver volume loss was noted within 3 weeks for 88% of participants, with 47% achieving their maximal liver volume reduction after the first week of an LCD. The mean reduction in liver volume was 16%, 18.6%, and 19% for MRI, ultrasound, and body composition analysis, respectively.
Close to 90% of patients require 3 weeks or less on an LCD to achieve maximal liver volume loss prior to laparoscopic anti-reflux surgery. Body composition analysis and bedside ultrasonography were both as accurate as the gold standard MRI in the assessment of liver volume.
极低热量饮食(VLCD)或低热量饮食(LCD)常用于腹腔镜手术前,以优化裂孔的进入。在文献中,关于 VLCD 或 LCD 的所需持续时间以及如何评估脂肪肝的存在存在很多争议。我们的研究目的是确定在 LCD 上实现最大肝体积减少的最佳时间,并评估 InBody 230®与床旁超声与磁共振成像(MRI)在测量肝体积方面的准确性。
招募了 17 名连续接受腹腔镜抗反流手术的患者参与研究。每位患者均接受 InBody®230 身体成分分析、肝脏超声和肝脏 MRI。然后,患者开始进行 LCD,每周进行超声评估,直到手术前一天,再次进行身体成分分析、肝脏超声和 MRI。
患者的平均年龄为 54 岁(范围 21-74 岁)。88%的患者在 3 周内达到最大肝体积丢失,47%的患者在进行 LCD 的第一周后达到最大肝体积减少。MRI、超声和身体成分分析分别测量的肝体积平均减少 16%、18.6%和 19%。
近 90%的患者在腹腔镜抗反流手术前需要进行 3 周或更短时间的 LCD,以实现最大肝体积减少。身体成分分析和床旁超声与金标准 MRI 一样准确地评估肝体积。